Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
6
result was found. Results that relate to
Pharmacoeconomics
Pharmacoeconomic evaluation of Huangkui capsule versus losartan potassium tablets in the treatment of IgA nephropathy
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(1):02-09.
817 times
358 times
Liang-Wen GOU
Zhao-Ting GUO
Qiong LUO
Nan YANG
Ming HU
Huangkui capsule
Losartan potassium tablets
Chronic kidney disease
Pharmacoeconomics
Cost-utility analysis
Details
Bibliometric analysis of pharmacoeconomics evaluation research in China: based on the Web of Science database
Published on
Journal of Mathematical Medicine
2023,36(3):185-193.
697 times
273 times
Yu-Liang GUI
Shi-Qiang XIANG
Pharmacoeconomics
evaluation
CiteSpace
Bibliometrics
Visual analysis
Details
Cost-utility analysis of azacitidine versus decitabine in the treatment of myelodysplastic syndrome
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1371-1379.
379 times
178 times
La-Ji DANZENG
Yong-Gong YANG
Si-Liang WANG
Meng-Ying LIU
Azacitidine
Decitabine
Myelodysplastic syndrome
Markov model
Cost-utility analysis
Pharmacoeconomics
Details
Pharmacoeconomic study of Bailing capsules plus conventional therapy in treating diabetic kidney disease
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):277-290.
420 times
201 times
HE Yumei
LI Wei
ZHU He
HAN Sheng
Bailing capsules
Diabetic kidney disease
Meta-analysis
Cost- effectiveness analysis
Pharmacoeconomics
Details
Partitioned survival model of pharmacoeconomics evaluation of oncology therapy in R language
Published on
Journal of Mathematical Medicine
2024,37(4):240-251.
346 times
146 times
LIU Jiayi
LI Wei
R language
Pharmacoeconomics
evaluation
Health economic evaluation
Partitioned survival model
Oncology treating drugs
Details
Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(4):388-401.
257 times
491 times
YU Tian
LIU Shaohua
WEI Anhua
GUO Jieru
ZHANG Chengliang
LIU Dong
LIU Zhelong
Glucagon-like peptide-1 receptor agonist
Metformin
Type 2 diabetes mellitus
Cost-utility
Markov model
Pharmacoeconomics
Details